Matteo Lambertini

Also affiliated with Azienda Ospedaliera di Perugia, Azienda Ospedaliera S.Maria, Ospedale Policlinico San Martino, University of Genoa

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 7%percentile

0.128Author DataRank

Indexed papers

4in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 4 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Association of Germline BRCA Pathogenic Variants with Diminished Ovarian Reserve: A Meta-Analysis of Individual Patient-Level Data

medRxiv(2021)10.1101/2021.02.13.21251672

Top 71%

0.128DataRank

Top 71%1 citations

Matteo Lambertini, Dong‐Yun Lee, Erica T. Wang, Florian Clatot, Beth Y. Karlan +4 more

Papers

Driven by 13 papers — median percentile 29. Top paper: “Trastuzumab as first-line therapy in HER2-positive metastatic breast cancer patients”.

Trastuzumab as first-line therapy in HER2-positive metastatic breast cancer patients

Expert Review of Anticancer Therapy(2012)10.1586/era.12.107

N/A

1.6DataRank · unranked

23 citations

Matteo Lambertini, Claudia Bighin, Alessia Levaggi, Alessia D’Alonzo, Sara Giraudi +2 more

Association between risk-reducing surgeries and survival in young BRCA carriers with breast cancer: an international cohort study

The Lancet Oncology(2025)10.1016/s1470-2045(25)00152-4

N/A

1.3DataRank · unranked

47 citations

Amir Sonnenblick, Elisa Agostinetto, Raphaëlle Bas, Hee Jeong Kim, Maria Alice Franzoi +44 more

Pregnancy After Breast Cancer in Young BRCA Carriers

JAMA(2024)10.1001/jama.2023.25463

N/A

0.614DataRank · unranked

59 citations

Eva Blondeaux, Elisa Agostinetto, Anne-Sophie Hamy, Hee Jeong Kim, Antonio Di Meglio +199 more

Spatial multiomics of the breast tumour microenvironment: State of the field, advancements and clinical implementation promises

Critical Reviews in Oncology/Hematology(2026)10.1016/j.critrevonc.2025.105082

N/A

0.269DataRank · unranked

5 citations

Haris Annette Benjamin, Serafina Martella, Pushpamali De Silva, Ioannis Stylianakis, Nerina Denaro +7 more

Association between type and location of germline BRCA1/2 pathogenic or likely pathogenic variants with phenotype and prognosis in young patients with breast cancer: results from an international cohort study

Annals of Oncology(2025)10.1016/j.annonc.2025.11.004

N/A

0.208DataRank · unranked

3 citations

Eva Blondeaux, Elena Tenedini, Lia Bonamici, Rossella Graffeo, L Livraghi +54 more

Association of Germline BRCA Pathogenic Variants with Diminished Ovarian Reserve: A Meta-Analysis of Individual Patient-Level Data

medRxiv(2021)10.1101/2021.02.13.21251672

Top 71%

0.128DataRank

Top 71%1 citations

Matteo Lambertini, Dong‐Yun Lee, Erica T. Wang, Florian Clatot, Beth Y. Karlan +4 more

Trends and Regional Differences for Fertility Preservation Procedures in Women With Breast Cancer

Clinical Breast Cancer(2024)10.1016/j.clbc.2024.09.011

N/A

0DataRank · unranked

2 citations

Giuliano Bedoschi, Dong‐Yun Lee, Caio Parente Barbosa, Renato de Oliveira, Koray Görkem Saçıntı +11 more

Characterization of HER2‐low breast cancer in young women with germline BRCA1/2 pathogenetic variants: Results of a large international retrospective cohort study

Cancer(2024)10.1002/cncr.35323

N/A

0DataRank · unranked

20 citations

Eva Blondeaux, Chiara Molinelli, Raphaëlle Bas, Hee Jeong Kim, Antonio Di Meglio +40 more

Impact of hormone receptor status and tumor subtypes of breast cancer in young BRCA carriers

Annals of Oncology(2024)10.1016/j.annonc.2024.06.009

N/A

0DataRank · unranked

28 citations

Marco Bruzzone, R. Bas, Hyun Jin Kim, Antonio Di Meglio, Rinat Bernstein‐Molho +41 more

Breastfeeding after breast cancer in young BRCA carriers

JNCI Journal of the National Cancer Institute(2025)10.1093/jnci/djaf177

N/A

0DataRank · unranked

5 citations

Virginia Delucchi, Elene Mariamidze, Rinat Bernstein‐Molho, Sophie Frank, Alberta Ferrari +37 more

Previous immune checkpoint inhibitor therapy is associated with decreased COVID-19-related hospitalizations and complications in patients with cancer: Results of a propensity-matched analysis of the OnCovid registry

International Journal of Infectious Diseases(2023)10.1016/j.ijid.2023.11.021

N/A

0DataRank · unranked

3 citations

Samuel Minkove, Isabel Ruíz-Camps, Simeón Eremiev, Gino M Dettorre, María Laura Fox +39 more

Safety of pregnancy after breast cancer in young women with hormone receptor-positive disease: a systematic review and meta-analysis

ESMO Open(2023)10.1016/j.esmoop.2023.102031

N/A

0DataRank · unranked

31 citations

Eva Blondeaux, Marco Bruzzone, Maria Maddalena Latocca, Elene Mariamidze, S. Begijanashvili +16 more

PREDICT underestimates survival of patients with HER2-positive early-stage breast cancer

npj Breast Cancer(2022)10.1038/s41523-022-00452-8

N/A

0DataRank · unranked

13 citations

Lieveke Ameye, Samuel Martel, Philippe Aftimos, Noam Pondé, Christian Maurer +15 more

Matteo Lambertini

Indexed papers

Top data-sharing exemplar

Papers